| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.082 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |